Overview
Huxley provides specialized IT staffing and project solutions in the finance sector. It helps financial technology teams by advising businesses, assembling expert groups, and delivering project work, with consultants focused on regional market needs. How it works: Huxley uses its deep fintech, business intelligence, and strategic transformation expertise to match the right professionals to the right projects, ensuring compliance and adherence to local and global standards through regular audits. How it stands out: its consultants are highly specialized by region, enabling market-specific advice and reliable placement of professionals, backed by global reach and strict compliance. The goal: help financial organizations shape their capabilities and perform better by pairing them with the right talent and project teams, accelerating transformation in the finance industry.
Work here?Claim your company
Simplify's take
What believers are saying
- June 2026 usage exceeded 1,000 physicians and tens of thousands of patients.
- December 2025 FDA ECG clearance widened SANSA’s clinical pitch beyond apnea testing.
- Huxley’s September 2026 financing signals investor support after strong commercial traction.
What critics are saying
- ResMed, ZOLL Itamar, and Onera are crowding sleep-diagnostics workflows in 2026.
- September 2026’s $11 million raise leaves Huxley undercapitalized against bigger device incumbents.
- If payer reimbursement stalls through 2027, SANSA stays clinically loved but financially weak.
What makes Huxley unique
- SANSA is the only FDA-cleared patch for obstructive sleep apnea, central sleep apnea, and ECG.
- June 2026 SANSA GO moved enrollment into clinics, cutting friction versus mailed sleep tests.
- Huxley’s cloud workflow and EHR integration fit cardiology, sleep medicine, and primary care.
Help us improve and share your feedback! Did you find this helpful?